Bacterial fatty acid biosynthesis: targets for antibacterial drug discovery.
暂无分享,去创建一个
[1] X. Yao,et al. Comparison of the backbone dynamics of the apo‐ and holo‐carboxy‐terminal domain of the biotin carboxy1 carrier subunit of Escherichia coli acety1‐CoA carboxylase , 2008, Protein science : a publication of the Protein Society.
[2] S. Abdel-Meguid,et al. Molecular basis for triclosan activity involves a flipping loop in the active site , 2008, Protein science : a publication of the Protein Society.
[3] R. Heath,et al. Inhibition of β-Ketoacyl-Acyl Carrier Protein Synthases by Thiolactomycin and Cerulenin , 2001, The Journal of Biological Chemistry.
[4] R. Slayden,et al. Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis , 2000, Molecular microbiology.
[5] N. Chirgadze,et al. Crystal structure of Streptococcus pneumoniae acyl carrier protein synthase: an essential enzyme in bacterial fatty acid biosynthesis , 2000, The EMBO journal.
[6] J. Cronan,et al. Overproduction of Acetyl-CoA Carboxylase Activity Increases the Rate of Fatty Acid Biosynthesis in Escherichia coli * , 2000, The Journal of Biological Chemistry.
[7] C. Rock,et al. Identification and substrate specificity of beta -ketoacyl (acyl carrier protein) synthase III (mtFabH) from Mycobacterium tuberculosis. , 2000, The Journal of biological chemistry.
[8] S. Gillespie,et al. Comparison of fitness of two isolates of Mycobacterium tuberculosis, one of which had developed multi-drug resistance during the course of treatment. , 2000, The Journal of infection.
[9] Charles O. Rock,et al. erratum: A triclosan-resistant bacterial enzyme , 2000, Nature.
[10] L. Bekker,et al. Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[11] K. Parris,et al. Crystal structures of substrate binding to Bacillus subtilis holo-(acyl carrier protein) synthase reveal a novel trimeric arrangement of molecules resulting in three active sites. , 2000, Structure.
[12] James C. Sacchettini,et al. Inactivation of the inhA-Encoded Fatty Acid Synthase II (FASII) Enoyl-Acyl Carrier Protein Reductase Induces Accumulation of the FASI End Products and Cell Lysis of Mycobacterium smegmatis , 2000, Journal of bacteriology.
[13] C. Townsend,et al. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. , 2000, Science.
[14] S. Parikh,et al. Inhibition of InhA, the enoyl reductase from Mycobacterium tuberculosis, by triclosan and isoniazid. , 2000, Biochemistry.
[15] D Alland,et al. Thiolactomycin and Related Analogues as Novel Anti-mycobacterial Agents Targeting KasA and KasB Condensing Enzymes inMycobacterium tuberculosis * , 2000, The Journal of Biological Chemistry.
[16] Y. Lindqvist,et al. Re-engineering ketoacyl synthase specificity. , 2000, Structure.
[17] H M Holden,et al. Movement of the Biotin Carboxylase B-domain as a Result of ATP Binding* , 2000, The Journal of Biological Chemistry.
[18] P. T. Englund,et al. Specialized fatty acid synthesis in African trypanosomes: myristate for GPI anchors. , 2000, Science.
[19] J. Harwood,et al. Novel inhibitors of the condensing enzymes of the type II fatty acid synthase of pea (Pisum sativum). , 2000, The Biochemical journal.
[20] J. Rafferty,et al. The X-ray structure of Brassica napus beta-keto acyl carrier protein reductase and its implications for substrate binding and catalysis. , 2000, Structure.
[21] C. Townsend,et al. Synthesis and antitumor activity of an inhibitor of fatty acid synthase , 2000 .
[22] R. Heath,et al. Inhibition of the Staphylococcus aureusNADPH-dependent Enoyl-Acyl Carrier Protein Reductase by Triclosan and Hexachlorophene* , 2000, The Journal of Biological Chemistry.
[23] M. Jaquinod,et al. Fatty Acid and Lipoic Acid Biosynthesis in Higher Plant Mitochondria* , 2000, The Journal of Biological Chemistry.
[24] R. Slayden,et al. Use of genomics and combinatorial chemistry in the development of new antimycobacterial drugs. , 2000, Biochemical pharmacology.
[25] R. Heath,et al. The 1.8 A crystal structure and active-site architecture of beta-ketoacyl-acyl carrier protein synthase III (FabH) from escherichia coli. , 2000, Structure.
[26] C. Walsh,et al. Holo-(Acyl Carrier Protein) Synthase and Phosphopantetheinyl Transfer in Escherichia coli * , 2000, The Journal of Biological Chemistry.
[27] R. Strongin,et al. Inhibition of biotin carboxylase by a reaction intermediate analog: implications for the kinetic mechanism. , 1999, Biochemical and biophysical research communications.
[28] S. Abdel-Meguid,et al. Crystal structure of beta-ketoacyl-acyl carrier protein synthase III. A key condensing enzyme in bacterial fatty acid biosynthesis. , 1999, The Journal of biological chemistry.
[29] S. Larsen,et al. CRYSTAL STRUCTURE OF BETA-KETOACYL-[ACYL CARRIER PROTEIN] SYNTHASE I FROM ESCHERICHIA COLI , 1999 .
[30] P. Brown,et al. Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[31] D W Rice,et al. Inhibitor Binding Studies on Enoyl Reductase Reveal Conformational Changes Related to Substrate Recognition* , 1999, The Journal of Biological Chemistry.
[32] S. Larsen,et al. The X‐ray crystal structure of β‐ketoacyl [acyl carrier protein] synthase I , 1999 .
[33] A. Chapman-Smith,et al. The enzymatic biotinylation of proteins: a post-translational modification of exceptional specificity. , 1999, Trends in biochemical sciences.
[34] I. Taylor,et al. Kinetic and structural characteristics of the inhibition of enoyl (acyl carrier protein) reductase by triclosan. , 1999, Biochemistry.
[35] I. H. Lim,et al. Contribution of kasA Analysis to Detection of Isoniazid-Resistant Mycobacterium tuberculosisin Singapore , 1999, Antimicrobial Agents and Chemotherapy.
[36] T. Schaeverbeke,et al. In-vitro activity of grepafloxacin, a new fluoroquinolone, against mycoplasmas. , 1999, The Journal of antimicrobial chemotherapy.
[37] T. Morris,et al. Solution structures of apo and holo biotinyl domains from acetyl coenzyme A carboxylase of Escherichia coli determined by triple-resonance nuclear magnetic resonance spectroscopy. , 1999, Biochemistry.
[38] R J Heath,et al. Mechanism of Triclosan Inhibition of Bacterial Fatty Acid Synthesis* , 1999, The Journal of Biological Chemistry.
[39] Antoni R. Slabas,et al. Molecular basis of triclosan activity , 1999, Nature.
[40] G. Schneider,et al. Structure of the Complex between the Antibiotic Cerulenin and Its Target, β-Ketoacyl-Acyl Carrier Protein Synthase* , 1999, The Journal of Biological Chemistry.
[41] P. McDermott,et al. Genetic Evidence that InhA of Mycobacterium smegmatis Is a Target for Triclosan , 1999, Antimicrobial Agents and Chemotherapy.
[42] D. Rice,et al. Molecular genetic analysis of enoyl‐acyl carrier protein reductase inhibition by diazaborine , 1999, Molecular microbiology.
[43] R. Heath,et al. Broad Spectrum Antimicrobial Biocides Target the FabI Component of Fatty Acid Synthesis* , 1998, The Journal of Biological Chemistry.
[44] Sonya S. Shin,et al. The dilemma of MDR-TB in the global era. , 1998, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[45] D. Roos,et al. Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[46] S. Levy,et al. Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. , 1998, FEMS microbiology letters.
[47] E. Schweizer,et al. A Novel Phosphopantetheine:Protein Transferase Activating Yeast Mitochondrial Acyl Carrier Protein* , 1998, The Journal of Biological Chemistry.
[48] S. Levy,et al. Triclosan targets lipid synthesis , 1998, Nature.
[49] J. Cronan,et al. Transcriptional Analysis of Essential Genes of theEscherichia coli Fatty Acid Biosynthesis Gene Cluster by Functional Replacement with the Analogous Salmonella typhimurium Gene Cluster , 1998, Journal of bacteriology.
[50] David A. Mead,et al. Inhibition of a Mycobacterium tuberculosis β-Ketoacyl ACP synthase by isoniazid , 1998 .
[51] T. Weisbrod,et al. NADH Dehydrogenase Defects Confer Isoniazid Resistance and Conditional Lethality in Mycobacterium smegmatis , 1998, Journal of bacteriology.
[52] J. Cronan,et al. A Bacillus subtilis Gene Induced by Cold Shock Encodes a Membrane Phospholipid Desaturase , 1998, Journal of bacteriology.
[53] G. Schneider,et al. Crystal structure of β‐ketoacyl‐acyl carrier protein synthase II from E.coli reveals the molecular architecture of condensing enzymes , 1998, The EMBO journal.
[54] J. Sacchettini,et al. Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. , 1998, Science.
[55] J. Cronan,et al. A New Metabolic Link , 1997, The Journal of Biological Chemistry.
[56] S. Brody,et al. Mitochondrial acyl carrier protein is involved in lipoic acid synthesis in Saccharomyces cerevisiae , 1997, FEBS letters.
[57] J. Ohlrogge,et al. Why do mitochondria synthesize fatty acids? Evidence for involvement in lipoic acid production. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[58] Antoni R. Slabas,et al. A Mechanism of Drug Action Revealed by Structural Studies of Enoyl Reductase , 1996, Science.
[59] H. Bergler,et al. The enoyl-[acyl-carrier-protein] reductase (FabI) of Escherichia coli, which catalyzes a key regulatory step in fatty acid biosynthesis, accepts NADH and NADPH as cofactors and is inhibited by palmitoyl-CoA. , 1996, European journal of biochemistry.
[60] G. Besra,et al. Antimycobacterial action of thiolactomycin: an inhibitor of fatty acid and mycolic acid synthesis , 1996, Antimicrobial agents and chemotherapy.
[61] D. Sherman,et al. Biochemical and genetic data suggest that InhA is not the primary target for activated isoniazid in Mycobacterium tuberculosis. , 1996, The Journal of infectious diseases.
[62] R. Heath,et al. Roles of the FabA and FabZ β-Hydroxyacyl-Acyl Carrier Protein Dehydratases in Escherichia coli Fatty Acid Biosynthesis* , 1996, The Journal of Biological Chemistry.
[63] C. Rock,et al. Escherichia coli as a model for the regulation of dissociable (type II) fatty acid biosynthesis. , 1996, Biochimica et biophysica acta.
[64] J. L. Smith,et al. Structure of a dehydratase-isomerase from the bacterial pathway for biosynthesis of unsaturated fatty acids: two catalytic activities in one active site. , 1996, Structure.
[65] R. Heath,et al. Regulation of Fatty Acid Elongation and Initiation by Acyl-Acyl Carrier Protein in Escherichia coli(*) , 1996, The Journal of Biological Chemistry.
[66] W. Hendrickson,et al. Structure of the biotinyl domain of acetyl-coenzyme A carboxylase determined by MAD phasing. , 1995, Structure.
[67] R. Heath,et al. Enoyl-Acyl Carrier Protein Reductase (fabI) Plays a Determinant Role in Completing Cycles of Fatty Acid Elongation in Escherichia coli(*) , 1995, The Journal of Biological Chemistry.
[68] J. Cronan,et al. The Unmodified (Apo) Form of Escherichia coli Acyl Carrier Protein Is a Potent Inhibitor of Cell Growth (*) , 1995, The Journal of Biological Chemistry.
[69] J C Sacchettini,et al. Enzymatic characterization of the target for isoniazid in Mycobacterium tuberculosis. , 1995, Biochemistry.
[70] Z Dauter,et al. The Escherichia coli Malonyl-CoA:Acyl Carrier Protein Transacylase at 1.5-Å Resolution. , 1995, The Journal of Biological Chemistry.
[71] J. Cronan,et al. The putative fabJ gene of Escherichia coli fatty acid synthesis is the fabF gene , 1995, Journal of bacteriology.
[72] G. Bai,et al. Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis. , 1995, The Journal of infectious diseases.
[73] J. Sacchettini,et al. Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis , 1995, Science.
[74] C. Raetz,et al. An Escherichia coli gene (FabZ) encoding (3R)-hydroxymyristoyl acyl carrier protein dehydrase. Relation to fabA and suppression of mutations in lipid A biosynthesis. , 1994, The Journal of biological chemistry.
[75] J. Olsen,et al. The fabJ-encoded beta-ketoacyl-[acyl carrier protein] synthase IV from Escherichia coli is sensitive to cerulenin and specific for short-chain substrates. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[76] P. Schultz,et al. Mechanistic Studies of the Oxidation of Isoniazid by the Catalase Peroxidase from Mycobacterium tuberculosis , 1994 .
[77] W. Jacobs,et al. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. , 1994, Science.
[78] J. Rosner. Susceptibilities of oxyR regulon mutants of Escherichia coli and Salmonella typhimurium to isoniazid , 1993, Antimicrobial Agents and Chemotherapy.
[79] C. Rock,et al. Thiolactomycin resistance in Escherichia coli is associated with the multidrug resistance efflux pump encoded by emrAB , 1993, Journal of bacteriology.
[80] C. Rock,et al. The dedB (usg) open reading frame of Escherichia coli encodes a subunit of acetyl-coenzyme A carboxylase , 1992, Journal of bacteriology.
[81] J. Cronan,et al. The genes encoding the two carboxyltransferase subunits of Escherichia coli acetyl-CoA carboxylase. , 1992, The Journal of biological chemistry.
[82] S. Cole,et al. The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis , 1992, Nature.
[83] C. Rock,et al. Isolation and characterization of the beta-ketoacyl-acyl carrier protein synthase III gene (fabH) from Escherichia coli K-12. , 1992, The Journal of biological chemistry.
[84] J. Cronan,et al. The gene encoding the biotin carboxylase subunit of Escherichia coli acetyl-CoA carboxylase. , 1992, The Journal of biological chemistry.
[85] G. Högenauer,et al. envM genes of Salmonella typhimurium and Escherichia coli , 1989, Journal of bacteriology.
[86] J. Cronan. The E. coli bio operon: Transcriptional repression by an essential protein modification enzyme , 1989, Cell.
[87] Y. Iitaka,et al. Structure of thiolactomycin. , 1989, Acta crystallographica. Section C, Crystal structure communications.
[88] C. Rock,et al. Acetoacetyl-acyl carrier protein synthase. A target for the antibiotic thiolactomycin. , 1989, The Journal of biological chemistry.
[89] M. Yamada,et al. Effect of thiolactomycin on the individual enzymes of the fatty acid synthase system in Escherichia coli. , 1986, Journal of biochemistry.
[90] A. Kawaguchi,et al. Inhibition of fatty acid synthesis by the antibiotic thiolactomycin. , 1984, The Journal of antibiotics.
[91] M. Polacco,et al. β-Hydroxydecanoyl thio ester dehydrase does not catalyze a rate-limiting step in Escherichia coli unsaturated fatty acid synthesis , 1983 .
[92] H. Okazaki,et al. Mechanism of action of the antibiotic thiolactomycin inhibition of fatty acid synthesis of Escherichia coli. , 1983, Biochemical and biophysical research communications.
[93] J. Cronan,et al. Genetic and Biochemical Analyses of Escherichia coli Mutants Altered in the Temperature-Dependent Regulation of Membrane Lipid Composition , 1983, Journal of bacteriology.
[94] S. Ōmura,et al. Thiotetromycin, a new antibiotic. Taxonomy, production, isolation, and physicochemical and biological properties. , 1983, The Journal of antibiotics.
[95] Y. Harada,et al. Thiolactomycin, a new antibiotic. IV. Biological properties and chemotherapeutic activity in mice. , 1982, The Journal of antibiotics.
[96] H. Sasaki,et al. Thiolactomycin, a new antibiotic. II. Structure elucidation. , 1982, The Journal of antibiotics.
[97] H. Okazaki,et al. Thiolactomycin, a new antibiotic. III. In vitro antibacterial activity. , 1982, The Journal of antibiotics.
[98] H. Okazaki,et al. THIOLACTOMYCIN, A NEW ANTIBIOTIC , 1982 .
[99] M. Polacco,et al. A mutant of Escherichia coli conditionally defective in the synthesis of holo-[acyl carrier protein]. , 1981, The Journal of biological chemistry.
[100] J. Cronan,et al. Structural, enzymatic, and genetic studies of beta-ketoacyl-acyl carrier protein synthases I and II of Escherichia coli. , 1980, The Journal of biological chemistry.
[101] J. Cronan,et al. Beta-ketoacyl-acyl carrier protein synthase II of Escherichia coli. Evidence for function in the thermal regulation of fatty acid synthesis. , 1980, The Journal of biological chemistry.
[102] L. Ingram,et al. Inhibition of unsaturated fatty acid synthesis in escherichia coli by the antibiotic cerulenin. , 1978, Biochemistry.
[103] S. Ōmura. The antibiotic cerulenin, a novel tool for biochemistry as an inhibitor of fatty acid synthesis. , 1976, Bacteriological reviews.
[104] S Omura,et al. Inhibition of fatty acid synthesis by the antibiotic cerulenin. Specific inactivation of beta-ketoacyl-acyl carrier protein synthetase. , 1973, Biochimica et biophysica acta.
[105] S. Ōmura,et al. Inhibition of fatty acid synthetases by the antibiotic cerulenin. , 1972, Biochemical and biophysical research communications.
[106] S. Nomura,et al. The action mechanism of cerulenin. I. Effect of cerulenin on sterol and fatty acid biosynthesis in yeast. , 1972, Journal of biochemistry.
[107] K. Bloch,et al. Mycobacterium phlei Fatty Acid Synthetase—A Bacterial Multienzyme Complex , 1969, Nature.
[108] K. Bloch,et al. Unsaturated fatty acids in microorganisms. , 1962, The Journal of biological chemistry.
[109] H. Goldfine,et al. On the origin of unsaturated fatty acids in clostridia. , 1961, The Journal of biological chemistry.
[110] E. J. Thomas,et al. Asymmetric synthesis of 5,5-disubstituted thiotetronic acids using anallyl xanthate to dithiocarbonate rearrangement: total synthesis of(5S)-thiolactomycin with revision of the absolute configurationof the natural , 1997 .
[111] D van Soolingen,et al. Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance. , 1996, The Journal of infectious diseases.
[112] M. Marahiel,et al. A new enzyme superfamily - the phosphopantetheinyl transferases. , 1996, Chemistry & biology.
[113] S. Iwasaki,et al. Effect of side-chain structure on inhibition of yeast fatty-acid synthase by cerulenin analogues. , 1993, European journal of biochemistry.
[114] I. V. Still,et al. Synthesis of 2-butenolide and tetronic acid analogs of thiolactomycin , 1989 .
[115] S. Kauppinen,et al. β-ketoacyl-ACP synthase I of Escherichia coli: Nucleotide sequence of thefabB gene and identification of the cerulenin binding residue , 1988, Carlsberg research communications.
[116] David J. Williams,et al. An asymmetric synthesis of thiotetronic acids using chirality transfer via an allyl xanthate-to-dithiocarbonate rearrangement. X-Ray crystal structure of (5R)-2,5-dihydro-4-hydroxy-5-methyl-3-phenyl-5-prop-1′-enyl-2-oxothiophene , 1987 .
[117] O. Sebek,et al. Isolation and structure of antibiotic U-68,204, a new thiolactone. , 1986, The Journal of antibiotics.
[118] P. Sedmera,et al. Two thiolactones from Streptomyces Tü 2476. , 1985, The Journal of antibiotics.
[119] J. Salvino,et al. Total ssynthesis of (±) thiolactomycin☆ , 1984 .
[120] Y. Shizuri,et al. Isolation and structure of citroethiolactone, a novel metabolite of Penicillium citreo-viride B. , 1983 .
[121] M. Lane,et al. Biotin carboxylase component of acetyl-CoA carboxylase from Escherichia coli. , 1975, Methods in enzymology.
[122] M. Lane,et al. Carboxyltransferase component of acetyl-CoA carboxylase from Escherichia coli. , 1975, Methods in enzymology.
[123] K. Bloch. 15 β-Hydroxydecanoyl Thioester Dehydrase , 1971 .